AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...
Residents of one of the most polluted areas of Delhi complain of blurred vision, persistent ...
Delhi's air quality has plummeted to alarming levels, particularly in Anand Vihar, causing severe health issues for residents ...
Global Respiratory Disease Testing Market to Grow at a CAGR of ~4% by 2030 | DelveInsight
DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...